Sionna Therapeutics Inc.

NASDAQ: SION · Real-Time Price · USD
20.89
-0.02 (-0.10%)
At close: Aug 15, 2025, 3:59 PM
20.82
-0.34%
After-hours: Aug 15, 2025, 04:04 PM EDT

Sionna Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q2 2024 Q1 2024 Q4 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Revenue
n/a n/a n/a n/a n/a n/a
Cost of Revenue
313K 166K 166K 166K n/a n/a
Gross Profit
-313K -166K -166K -166K n/a n/a
Operating Income
-70.99M -62.23M -55.17M -37.03M -25.74M -12.6M
Interest Income
11.35M 8.82M 6.37M 4.25M 1.69M 553K
Pretax Income
-58.95M -52.73M -48.12M -32.27M -23.72M -11.88M
Net Income
-58.95M -52.73M -48.12M -32.27M -23.72M -11.88M
Selling & General & Admin
18.86M 14.89M 12.04M 8.16M 5.27M 2.71M
Research & Development
51.54M 46.37M 42.6M 28.34M 20.11M 9.89M
Other Expenses
284K 797K 366K 366K 366K n/a
Operating Expenses
70.68M 62.06M 55M 36.87M 25.74M 12.6M
Interest Expense
n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a
Cost & Expenses
70.99M 62.23M 55.17M 37.03M 25.74M 12.6M
Income Tax Expense
n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
44.12M 26.6M 42.4M 44.12M 27.8M 17.33M
Shares Outstanding (Diluted)
44.12M 26.6M 42.4M 44.12M 27.8M 17.33M
EPS (Basic)
-1.59 -1.61 -1.68 -1.31 -1.12 -0.69
EPS (Diluted)
-1.59 -1.61 -1.68 -1.31 -1.12 -0.69
EBITDA
-67.49M -58.36M -51.57M -33.6M -25.21M -12.43M
EBIT
-64.41M -59.49M -52.43M -34.29M -25.74M -12.6M
Depreciation & Amortization
639K 658K 660K 493K 327K 161K